Selehold 45 mg spot-on solution for cats 2.6–7.5 kg
Selehold 45 mg spot-on solution for cats 2.6–7.5 kg
Authorised
- Selamectin
Product identification
Medicine name:
Selehold 45 mg spot-on solution for cats 2.6–7.5 kg
Selehold 45 mg voor katten 2,6 - 7,5 kg 60 mg/ml Spot-on oplossing
Selehold 45 mg pour chats 2,6 - 7,5 kg 60 mg/ml Solution pour spot-on
Selehold 45 mg fur Katzen 2,6 - 7,5 kg 60 mg/ml Lösung zum Auftropfen
Active substance:
- Selamectin
Target species:
-
Cat
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
-
Selamectin45.00milligram(s)1.00Pipette
Pharmaceutical form:
-
Spot-on solution
Withdrawal period by route of administration:
-
Spot-on use
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AA05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 1 pipette.
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 3 pipettes.
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 6 pipettes.
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene. 3 ml pipette containing 0.75 ml of solution.Cardboard box containing 15 pipettes.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- TAD Pharma GmbH
- KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V537893
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0394/002
Concerned member states:
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?: